Luke T. Nordquist, MD

Dr. Luke Nordquist is a Medical Oncologist with an expertise in Prostate Cancer. He is the Founder and CEO of XCancer® in Omaha, NE. Dr. Luke and the XCancer® team are globally recognized for their many contributions to the advancement of novel imaging and therapies for prostate cancer. The XCancer® team are often considered as a go to site for rapid startup, phase 1 trials because of their focus, quality and exceptional efficiency. XCancer® has the ability to open a clinical trial in a few weeks. As of 2024, Dr. Luke and his team have accrued more than 1500 patient to clinical trials and conducted more than 20 First-in-World clinical trials for Prostate Cancer. They have extensive experience with many radioisotopes having conducted more than 40 radiopharmaceutical imaging and therapeutic trials. His team accrued the first patient, the most patients and had the highest quality data on the Lu177 PSMA Vision Trial. More than 450 prostate cancer patients every month from more than 40 states and several countries travel to Dr. Luke in Omaha for their prostate cancer care. To improve education, awareness, and access to radiopharmaceutical clinical trials globally, Dr. Luke developed TheranosticTrials.org. XCancer® also has developed a strategic program, business knowledge, and training curriculum to assist other Medical Oncologists & Community Cancer Centers from coast to coast in developing radiopharmaceutical programs that are able to conduct early to late phase clinical trials. XCancer® is helping assist cancer care as far away as Tanzania, Africa. The XCancer® Foundation, funded the construction of a cancer housing hostel at the Kilimanjaro Christian Medical Center (KCMC) in Moshi, Tanzania. Omaha, NE USA Contact Information: For Patient Appointments: Patient Advocate Desk: 402-991-8468 For Clinical Trials: Tony Romero 402-991-8468 For Industry/Business Meetings: Stacy Moore 402-991-8468 drluke@xcancer.com